Association between nonalcoholic fatty liver disease and carotid atherosclerosis: A meta-analysis

International Journal of Clinical and Experimental Medicine

Volumn 8, Issue 5, 2015, Pages 7673-7678

  Cai, Jia ^a   Zhang, Shujun ^a   Huang, Wenxiang ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Atherosclerosis; Carotid artery; Carotid intima media thickness; Meta analysis; Non alcoholic fatty liver disease

Indexed keywords

GLUCOSE; LIVER ENZYME;

ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROTIC PLAQUE; BLOOD PRESSURE; BODY MASS; CAROTID ATHEROSCLEROSIS; CLINICAL ASSESSMENT; DISEASE ASSOCIATION; ECHOGRAPHY; HISTOLOGY; HUMAN; META ANALYSIS; NONALCOHOLIC FATTY LIVER; PUBLICATION;

EID: 84936990596     PISSN: None     EISSN: 19405901     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. [1] Oda K, Uto H, Mawatari S, Ido A. Clinical features of hepatocellular carcinoma associated with nonalcoholic fatty liver disease: a review of human studies. Clin J Gastroenterol 2015; 8: 1-9.
2. [2] Bellentani S, Scaglioni F, Marino M, Bedogni G. Epidemiology of non-alcoholic fatty liver disease. Dig Dis 2010; 28: 155-61.
3. [3] Shen F, Zheng RD, Mi YQ, Shi JP, Chen GF, Chen JN, Xu L, Pan Q, Xu LM, Fan JG. A multi-center clinical study of a novel controlled attenuation parameter for assessment of fatty liver. Zhonghua Gan Zang Bing Za Zhi 2014; 22: 926-31.
4. [4] Treeprasertsuk S, Lopez-Jimenez F, Lindor KD. Nonalcoholic fatty liver disease and the coronary artery disease. Dig Dis Sci 2011; 56: 35-45.
5. [5] Picardi A, Vespasiani Gentilucci U. Association between non-alcoholic fatty liver disease and cardiovascular disease: a first message should pass. Am J Gastroenterol 2008; 103: 3036-8.
6. [6] Domanski JP, Park SJ, Harrison SA. Cardio-vascular disease and nonalcoholic fatty liver disease: does histologic severity matter? J Clin Gastroenterol 2012; 46: 427-30.
7. [7] Eikendal AL, Groenewegen KA, Anderson TJ, Britton AR, Engström G, Evans GW, de Graaf J, Grobbee DE, Hedblad B, Holewijn S, Ikeda A, Kitagawa K, Kitamura A, Lonn EM, Lorenz MW, Mathiesen EB, Nijpels G, Dekker JM, Okazaki S, O’Leary DH, Polak JF, Price JF, Robertson C, Rembold CM, Rosvall M, Rundek T, Salonen JT, Sitzer M, Stehouwer CD, Hoefer IE, Peters SA, Bots ML, den Ruijter HM; USE-IMT Project Group. Common Carotid Intima-Media Thick-ness Relates to Cardiovascular Events in Adults Aged & lt; 45 Years. Hypertension 2015; 65: 707-13.
8. [8] Gepner AD, Young R, Delaney JA, Tattersall MC, Blaha MJ, Post WS, Gottesman RF, Kronmal R, Budoff MJ, Burke GL, Folsom AR, Liu K, Kaufman J, Stein JH. Comparison of coronary artery calcium presence, carotid plaque presence, and carotid intima-media thickness for cardiovascular disease prediction in the multi-ethnic study of atherosclerosis. Circ Cardiovasc Imaging 2015; 8: e002262.
9. [9] Sert A, Pirgon O, Aypar E, Yılmaz H, Dündar B. Relationship between aspartate aminotransferase-to-platelet ratio index and carotid intima-media thickness in obese adolescents with non-alcoholic fatty liver disease. J Clin Res Pediatr Endocrinol 2013; 5: 182-8.
10. [10] Aygun C, Kocaman O, Sahin T, Uraz S, Eminler AT, Celebi A, Senturk O, Hulagu S. Evaluation of metabolic syndrome frequency and carotid artery intima-media thickness as risk factors for atherosclerosis in patients with nonalcoholic fatty liver disease. Dig Dis Sci 2008; 53: 1352-7.
11. [11] Brea A, Mosquera D, Martín E, Arizti A, Cordero JL, Ros E. Nonalcoholic fatty liver disease is associated with carotid atherosclerosis: a case-control study. Arterioscler Thromb Vasc Biol 2005; 25: 1045-50.
12. [12] Fracanzani AL, Burdick L, Raselli S, Pedotti P, Grigore L, Santorelli G, Valenti L, Maraschi A, Catapano A, Fargion S. Carotid artery intima-media thickness in nonalcoholic fatty liver disease. Am J Med 2008; 121: 72-8.
13. [13] Kang JH, Cho KI, Kim SM, Lee JY, Kim JJ, Goo JJ, Kim KN, Jhi JH, Kim DJ, Lee HG, Kim TI. Relationship between Nonalcoholic Fatty Liver Disease and Carotid Artery Atherosclerosis Beyond Metabolic Disorders in Non-Diabetic Patients. J Cardiovasc Ultrasound 2012; 20: 126-33.
14. [14] Mishra S, Yadav D, Gupta M, Mishra H, Sharma P. A Study of Carotid Atherosclerosis in Patients with Non-alcoholic Fatty Liver Disease. Indian J Clin Biochem 2013; 28: 79-83.
15. [15] Mohammadi A, Sedani HH, Ghasemi-Rad M. Evaluation of carotid intima-media thickness and flow-mediated dilatation in middle-aged patients with nonalcoholic fatty liver disease. Vasc Health Risk Manag 2011; 7: 661-5.
16. [16] Ramilli S, Pretolani S, Muscari A, Pacelli B, Arienti V. Carotid lesions in outpatients with nonalcoholic fatty liver disease. World J Gastroenterol 2009; 15: 4770-4.
17. [17] Targher G, Bertolini L, Padovani R, Poli F, Scala L, Zenari L, Zoppini G, Falezza G. Non-alcoholic fatty liver disease is associated with carotid artery wall thickness in diet-controlled type 2 diabetic patients. J Endocrinol Invest 2006; 29: 55-60.
18. [18] Targher G, Bertolini L, Padovani R, Zenari L, Zoppini G, Falezza G. Relation of nonalcoholic hepatic steatosis to early carotid atherosclerosis in healthy men: role of visceral fat accumulation. Diabetes Care 2004; 27: 2498-500.
19. [19] Higgins JP, Thompson SG, Decks JJ. Measuring inconsistency in meta analyses. BMJ 2003; 327: 557-560.
20. [20] Elsheikh E, Younoszai Z, Otgonsuren M, Hunt S, Raybuck B, Younossi ZM. Markers of endothelial dysfunction in patients with non-alcoholic fatty liver disease and coronary artery disease. J Gastroenterol Hepatol 2014; 29: 1528-34.
21. [21] Topuz M, Dogan A, Celik A, Can C, Ozdogru I, Kemal Eryol N. Investigation of the relationship between non-alcoholic fatty liver disease andcoronary artery disease. Clin Ter 2014; 165: e46-51.
22. [22] Josef P, Ali I, Ariel P, Alon M, Nimer A. Relationship between retinal vascular caliber and coronary artery disease in patients with non-alcoholic fatty liver disease (NAFLD). Int J Environ Res Public Health 2013; 10: 3409-23.
23. [23] Schindhelm RK, Diamant M, Bakker SJ, van Dijk RA, Scheffer PG, Teerlink T, Kostense PJ, Heine RJ. Liver alanine aminotransferase, insulin resistance and endothelial dysfunction in normotriglyceridaemic subjects with type 2 diabetes mellitus. Eur J Clin Invest 2005; 35: 369-74.
24. [24] Villanova N, Moscatiello S, Ramilli S, Bugianesi E, Magalotti D, Vanni E, Zoli M, Marchesini G. Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease. Hepatology 2005; 42: 473-80.
25. [25] Fraser A, Harris R, Sattar N, Ebrahim S, Smith GD, Lawlor DA. Gamma-glutamyltransferase is associated with incident vascular events independently of alcohol intake: analysis of the British Women’s Heart and Health Study and Meta-Analysis. Arterioscler Thromb Vasc Biol 2007; 27: 2729-35.